Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo.
BMC Cancer
; 17(1): 216, 2017 03 24.
Article
in En
| MEDLINE
| ID: mdl-28340556
Full text:
1
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Thiadiazines
/
Antineoplastic Agents
Limits:
Animals
/
Humans
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2017
Type:
Article
Affiliation country:
Germany